철 킬레이트화 치료를 중단한 철과잉증 환자의 생간건비탕을 사용한 치험 1례
Case of an Iron Overload Patient Who Discontinued Iron Chelation Therapy and Was Treated with Saenggangunbi-tang
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: This study identified the effect of Korean medicine treatment on a patient with iron overload who discontinued iron chelation therapy. Methods: A 64-year-old woman with iron overload was treated with Saenggangunbi-tang from November 14, 2022, to March 15, 2023, to reduce fatigue and improve laboratory findings. We observed changes in the symptoms and improvement of laboratory findings during the four-month treatment. Results: The approximately four-month treatment with Saenggangunbi-tang showed considerable improvement in laboratory findings and fatigue. In addition, no adverse effects, such as liver injury, were observed during Korean medicine treatment. Conclusion: This study suggests the availability of Saenggangunbi-tang as a therapeutic option for managing patients with iron overload.
Abstract
Objectives: This study identified the effect of Korean medicine treatment on a patient with iron overload who discontinued iron chelation therapy. Methods: A 64-year-old woman with iron overload was treated with Saenggangunbi-tang from November 14, 2022, to March 15, 2023, to reduce fatigue and improve laboratory findings. We observed changes in the symptoms and improvement of laboratory findings during the four-month treatment. Results: The approximately four-month treatment with Saenggangunbi-tang showed considerable improvement in laboratory findings and fatigue. In addition, no adverse effects, such as liver injury, were observed during Korean medicine treatment. Conclusion: This study suggests the availability of Saenggangunbi-tang as a therapeutic option for managing patients with iron overload.
참고문헌 (20)
- 김혁, "수혈성 철과잉증의 진단 및 치료", 대한의사협회지, 65(10), pp.662~672 (2022), 대한의사협회[DOI]
- Hsu CC, "Iron overload disroders", Hepatol Commun, 6(8), pp.1842~1854 (2022)
- Radford-Smith DE, "Haemochromatosis : a clinical update for the practising physician", Intern Med J, 48(5), pp.509~516 (2018)
- Pietrangelo A, "Hereditary hemochromatosis : pathogenesis, diagnosis, and treatment", Gastroenterology, 139(2), pp.393~408 (2010)
- Fleming RE, "Iron Overload in Human Disease", N Engl J Med, 366(4), pp.348~359 (2012)
- "Iron Overload"[URL]
- Siah CW, "Iron overload", Clinica Chimica Acta, 358(1-2), pp.24~36 (2005)
- Park CH, "Hepcidin, a urinary antimicrobial peptide synthesized in the liver", J Biol Chem, 276(11), pp.7806~7810 (2001)
- Girelli D, "Hemochromatosis classification : update and recommendations by the BIOIRON Society", Blood, 139(20), pp.3018~3029 (2022)
- McLaren CE, "Hemochromatosis and Iron Overload Screening(HEIRS)study design for an evaluation of 100, 000 primary care-based adults", Am J Med Sci, 325(2), pp.53~62 (2003)
- 장준호, "Korean Guideline for Iron Chelation Therapy in Transfusion-Induced Iron Overload", Journal of Korean Medical Science, 28(11), pp.1563~1572 (2013), 대한의학회
- "LiverTox: Clinical and Research Information on Drug-Induced Liver Injury" (2017)[URL]
- 김어진, "비만과 이상지질혈증을 동반한 비알코올 지방간질환 환자 치험 1례", 대한한방내과학회지, 43(2), pp.184~190 (2022), 대한한방내과학회[DOI]
- 최홍식, "생간건비탕을 이용한 급성 약인성 간손상 치험 1례", 대한한방내과학회지, 25(4), pp.207~211 (2004), 대한한방내과학회
- 최정원, "解肝煎이 Thioacetamide로 유발된 간섬유화에 미치는 영향", 대한한방내과학회지, 43(4), pp.643~655 (2022), 대한한방내과학회[DOI]
- Bridle KR, "Disrupted hepcidin regulation in HFEassociated haemochromatosis and the liver as a regulator of body iron homoeostasis", Lancet, 361(9358), pp.669~673 (2003)
- Bacon BR, "The pathology of hepatic iron overload: a free radical-mediated process?", Hepatology, 11(1), pp.127~137 (1990)
- Hong JH, "Antioxidative and cytoprotective effects of Artemisia capillaris fractions", Biofactors, 31(1), pp.43~53 (2007)
- Adams P, "The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis", Hepatology, 25(1), pp.162~166 (1997)
- Murphy A, "The real impact of fatigue in Haemochromatosis", Irish Society of Gastroenterology. ISG Summer Meeting, pp.20~ (2016)